Power Law company profile

Momenta Pharmaceuticals

Biotech & Life Sciences · Cambridge, United States · Founded 2001 · IPO 2004 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$6.50B

Market cap · 2026

Revenue

$29M

Latest reported FY

Investors

5 investors on Momenta Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage

Polaris Partners

Series B+ 4 investors entered at this stage

Mithra Ventures

Atlas Venture

MVM Life Science Partners

Cardinal Partners

Global footprint

Where Momenta Pharmaceuticals has talent and traffic

Web traffic by country

1.8K monthly visits
across markets

🇺🇸 United States66.7%

🇵🇭 Philippines16.7%

🇬🇧 United Kingdom11.1%

🇹🇭 Thailand5.6%

Top 4 markets shown

Patent intelligence

$78M patent portfolio · 63 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$78M

1.2% of market cap · 26× smaller than top peer Ablynx ($2B)

63 active patent families

Where Momenta Pharmaceuticals innovates Molecular biologyPolysaccharideGlycanCell biologyChemistry

Below peer median on Legal, Strategic, Market, Technology

Quality vs same-sector peers

Momenta Pharmaceuticals on the five Patsnap quality dimensions

Momenta Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Momenta Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Momenta Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Momenta Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo